CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,431,111
- in 18 filings, $21.0M under 10b5-1 plans
Net −$21,431,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Quinlan Paul T −$2.6M General Counsel sold 49% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2006-08-25 | Titus Gary Chief Acct.Officer | Exercise or conversion | +10,000 | $9.67 | $97K | 12,633 |
| 2006-08-25 | Titus Gary Chief Acct.Officer | Sale | −10,000 | $20.00 | $200K | 2,633 |
| 2006-08-25 | Titus Gary Chief Acct.Officer | Exercise or conversion | +20,000 | $9.17 | $183K | 22,633 |
| 2006-08-25 | Titus Gary Chief Acct.Officer | Sale | −20,000 | $19.88 | $398K | 2,633 |
| 2006-08-24 | Titus Gary Chief Acct.Officer | Exercise or conversion | +15,000 | $9.83 | $147K | 17,633 |
| 2006-08-24 | Titus Gary Chief Acct.Officer | Sale | −15,000 | $19.50 | $293K | 2,633 |
| 2006-08-10 | SOBEL BURTON E Director | Exercise or conversion | +12,500 | $6.50 | $81K | 12,500 |
| 2006-08-10 | SOBEL BURTON E Director | Sale | −12,500 | $16.00 | $200K | 0 |
| 2006-08-01 | Titus Gary VP Finance, Chief Acct.Officer | Grant or award · Incentive Stock Option (right to buy) | +5,000 | $16.74 | $84K | 5,000 |
| 2006-08-01 | Titus Gary VP Finance, Chief Acct.Officer | Grant or award · Non Qualified Stock Option (right to buy) | +25,000 | $16.74 | $419K | 25,000 |
| 2006-08-01 | LOVE TED W C.E.O. | Grant or award · Non-Qualified Stock Option (right to buy) | +371,960 | 371,960 | ||
| 2006-08-01 | LOVE TED W C.E.O. | Grant or award · Incentive Stock Option (right to buy) | +3,040 | 3,040 | ||
| 2006-08-01 | LEVY MICHAEL D Sr. VP Research & Development | Grant or award · Non Qualified Stock Option (right to buy) | +74,025 | 74,025 | ||
| 2006-08-01 | LEVY MICHAEL D Sr. VP Research & Development | Grant or award · Incentive Stock Option (right to buy) | +5,975 | 5,975 | ||
| 2006-08-01 | BENDEKGEY E LEE Sr VP & General Counsel | Grant or award · Non Qualified Stock Option (right to buy) | +44,514 | 44,514 | ||
| 2006-08-01 | BENDEKGEY E LEE Sr VP & General Counsel | Grant or award · Incentive Stock Option (right to buy) | +5,486 | 5,486 | ||
| 2006-07-24 | Wolff Henry Ward Sr. VP Finance and CFO | Grant or award · Non-Qualified Stock Option (right to buy) | +151,508 | 151,508 | ||
| 2006-07-24 | Wolff Henry Ward Sr. VP Finance and CFO | Grant or award · Incentive Stock Option (right to buy) | +23,492 | 23,492 | ||
| 2006-05-31 | Titus Gary VP Finance, Chief Acct.Officer | Other acquisition | +90 | $13.90 | $1K | 2,633 |
| 2006-05-31 | LOVE TED W C.E.O. | Other acquisition | +1,132 | $13.90 | $16K | 4,423 |
Page 34 of 41 · 802 trades